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Abstract: Tetrodotoxin (TTX) is a powerful sodium channel blocker found in puffer fish 
and some marine animals. Cases of TTX poisoning most often result from puffer  fish 
ingestion. Diagnosis is mainly from patient’s signs and symptoms or the detection of TTX 
in  the  leftover  food.  If  leftover  food  is  unavailable,  the  determination  of  TTX  in  the 
patient’s  urine  and/or  plasma  is  essential  to  confirm  the  diagnosis.  Although  various 
methods for the determination of TTX have been published, most of them are for food 
tissue samples. Dealing with human urine and blood samples is much more challenging. 
Unlike  in  food,  the  amount  of  toxin  in  the  urine  and  blood  of  a  patient  is  generally 
extremely low; therefore a very sensitive method is required to detect it. In this regard, 
mass spectrometry (MS)  methods  are  the  best  choice.  Since  TTX  is  a  very  polar 
compound, there will be lack of retention on conventional reverse-phase columns; use of 
ion pair reagent or hydrophilic interaction liquid chromatography (HILIC) can help solve 
this  problem.  The problem of ion suppression is another challenge in analyzing polar 
compound in biological samples. This review will discuss different MS methods and their 
pros and cons. 
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1. Introduction 
Tetrodotoxin (TTX), a puffer fish toxin named after the fish’s order name Tetraodontiformes, is a 
potent neurotoxin. It is of low molecular weight, with a unique structure (Figure 1), only relatively 
recently  determined  in  1964  [1–3].  It  is  a  well  known  marine  toxin,  a  powerful  sodium  channel  
blocker [4,5] and is found not only in puffer fish but also in some gastropods. TTX binds to and blocks 
sodium channel found in excitable tissues such as nerves and muscle. The inhibition of sodium entry 
through ion channel renders these tissues nonfunctional. TTX is about 10,000 times more lethal than 
cyanide by weight; the lethal dose is about 1–2 mg for adults [6,7]. There are several other marine 
animals, such as Gobius cringer, horseshoe crabs, Costa Rican frog of the genus Atelopus, Australian 
blue-ring octopus and Californian newt, all of which if eaten, can cause poisoning. TTX poisoning is 
frequently encountered in Japan, Taiwan and Southeast Asia including Hong Kong, where fugu or 
puffer fish is considered a delicacy. According to the statistics of the Japanese Ministry of Health, 
Labor and Welfare, during the 5 years from 2002 to 2006, 116 incidents of puffer fish poisoning 
occurred in Japan, involving 223 patients and 13 deaths [8]. From 1993 to 2006, 10 incidents of puffer 
fish  poisoning  were  reported  in  Hong  Kong  [9]  which  involved  23  persons  with  1  fatality.  In 
Singapore, from 2001 to 2006, a total of 53 patients with the history of puffer fish ingestion were 
admitted to a regional hospital; among them, 8 died [10]. In Taiwan, from 2001 to 2004, two incidents 
of TTX intoxication occurred. One out of 6 patients died for the case in 2001 and 2 out of 6 patients 
died in 2004’s case report [11,12]. A more recent outbreak of TTX poisoning occurred in Bangladesh 
in 2008 which involved 141 patients, among them 17 patients died [13]. In Taiwan and China, some 
cases of TTX poisoning have been caused by the mistaken ingestion of the muscle tissue of a puffer 
fish species, by ingesting puffer roe that had been sold as fake dried mullet roe called “karasumi”, or 
by  ingesting  a  dried  dressed  fish  fillet  produced  from  toxic  puffer  fish  by  a  food  processing  
company [14–17]. In Asia, gastropods are widely used as a traditional food, and poisoning incidents 
associated with nassariid gastropods have been reported occasionally in Taiwan and mainland China 
since 1994 [18–20]. Overall, however, the main cause of TTX intoxications reported in Japan and 
South-east Asia is related to puffer fish ingestion. 
Figure 1. Structure of tetrodotoxin. 
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The  causative  agent  of  food  poisoning  is  usually  established  from  patient’s  symptoms  and 
identification of the toxins by analyzing leftovers of the suspected food eaten. In 1941, Fukuda and Mar. Drugs 2011, 9                                             
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Tani provided a clinical grading system for TTX poisoning [21,22]. This four-degree classification is 
based on symptoms and stages of progression, and is still of clinical value (Table 1). Three factors 
contribute to the degree of intoxication: the amount of TTX ingested, time lag after ingestion until 
admission to hospital, and pre-existing diseases. First- and second-degree cases are relatively mild; 
there is loss of some neuromuscular and neurological function, but reflexes are still intact. Third-degree 
poisoning is characterized by more severe disturbances, e.g., ataxia, widespread paralysis, pronounced 
hyporeflexia,  dropping  blood  pressure,  cyanosis,  and  respiratory  failure.  Fourth-degree  cases  are 
severely poisoned patients presenting with cessation of respiration, decreased arterial oxygen level, 
unconsciousness, brandycardia, and hypotension.  
Table 1. Clinical grading system in TTX intoxication according to [21,22]. 
Degree  Signs and Symptoms  Onset 
First 
Perioral numbness and paraesthesia, with or without 
gastrointestinal symptoms (mainly nausea). 
5–45 min 
Second 
Lingual numbness, numbness of face, and other areas (distal). 
Early motor paralysis and in-coordination. Slurred speech. 
Normal reflexes. 
10–60 min 
Third 
Generalized flaccid paralysis, respiratory failure, aphonia, 
and fixed or dilated pupils. Patient is conscious. 
15 min– 
several hours 
Fourth 
Severe respiratory failure and hypoxia.  
Hypotension, bradycardia, and cardiac dysrhythmias.  
Unconsciousness may occur. 
15 min–24 h 
Since there is no antidotes for TTX poisoning, treatment is mainly by supportive therapy and may 
involve mechanical ventilation for oxygen supply, normal saline infusion for distending the 
intravascular volume, gastric emptying procedures, or treatment with dopamine. Early diagnosis and 
prompt clinical management essentially contribute to low mortality rates. In Japan, the fatality rate fell 
from 80% at the beginning of the last century, with more than 100 deaths per year, to about 6% in the 
90 s [6,23,24] due to the improvement of early life-saving systems in emergency medicine. In other 
Asian countries, mortality rates between 2–22% were reported [10,25–27].  
Apart from diagnosing from signs and symptoms, analyzing TTX in leftover food is another way to 
make the diagnosis. However, leftover food is sometimes not available, either because it has not been 
brought with the patient to the hospital or because it has been discarded. Under such conditions, the 
detection of TTX in patient’s urine or blood is essential to confirm the diagnosis of TTX poisoning. As 
TTX is a very polar compound, the ingested toxin is mainly eliminated in urine. Previous studies have 
indicated that TTX only remains in the plasma component of the blood for a matter of hours (less than 
24 h), but can be found in urine even on day 4 after ingestion [28,29]. In light of this, urine TTX 
determination could be a better choice, for the purposes of clinical laboratory diagnosis, to confirm 
TTX poisoning. Furthermore, in order to eliminate the effect of dehydration and variations in urinary 
output, creatinine adjustment should be made for all urine samples. Mar. Drugs 2011, 9                                             
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2. Challenges of TTX Determination in Human Urine and Plasma 
Basically, determining TTX poisoning from body fluids faces three challenges. First, unlike in food, 
the amount of toxin in the urine and blood of a patient who has been poisoned is typically low; 
therefore a very sensitive method is required. Secondly, because TTX is a very polar compound, there 
will be little of any retention on conventional reverse-phase columns; thus, use of another type of 
analytical column such  as normal phase columns or modification of  mobile phase composition is 
required. Third, endogenous metabolites in urine are commonly very polar compounds, just like TTX, 
which may pose the problem of ion suppression in MS analysis. Thus, a very efficient sample clean-up 
procedure is required.  
2.1. Analytical Methods for TTX Determination—A Brief Overview 
The standard method accepted worldwide for determining TTX toxicity in food matrices is the 
mouse  bioassay  [30].  However,  biological  tests  are  not  completely  satisfactory,  due  to  their  low 
sensitivity and the absence of specialized variations. Moreover, there is growing resistance against the 
use  of  animals  in  experiments.  In  addition,  the  bioassay  is  not  suitable  for  measuring  TTX  in  a 
poisoned patient’s urine or blood samples. In this report we only focus on analytical methods for the 
determination of TTX in human urine and blood.  
Several analytical methods for detecting TTX in urine and blood samples of poisoned patients have 
been  reported,  namely:  gas  chromatography-mass  spectrometry  (GC-MS)  [31,32],  immunoaffinity 
chromatography [33], high performance liquid chromatography with post-column derivatization and 
fluorescence  detection  (HPLC-FLD)  [29],  HPLC  with  ultra violet (UV)  detection  [34]  and  liquid 
chromatography-mass spectrometry (LC-MS) [11,35]. Apart from the chromatography based methods, 
TTX in biological samples can also be measured by using a specific enzyme-linked immunosorbent 
assay (ELISA) [36]. Table  2  summarizes  several  reports  from  Asia,  but  not  a  complete  catalog  
of all cases of tetrodotoxication. TTX levels detected in urine and plasma/serum of patients with  
TTX  poisoning  and  the  analytical  methods  used  are  shown.  Among  these  methods,  the  GC-MS  
method required a complicated extraction process and is considered time-consuming—perhaps too 
time-consuming when a patient’s life is at stake. HPLC with either fluorescence or UV detection is 
generally limited in sensitivity. The immunoaffinity chromatography method shows relatively high 
sensitivity  in  detecting  TTX  in  urine,  but  requires  a  costly  monoclonal  antibody.  The ELISA   
method uses a monoclonal antibody with high specificity for TTX with fast analysis time of about  
30 min. [37], but it also requires a costly reagent. In contrast, LC-MS/MS for TTX determination in 
human  urine  and  blood  requires  a  simple  sample  preparation  when  compared  with  GC-MS  and 
provides a better limit of detection when compared with HPLC-FLD or HPLC-UV methods. The 
running cost of LC-MS/MS  is much cheaper when compared with the ELISA method. Table  3 
summarizes different analytical techniques for the determination of TTX in human urine and/or blood. 
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Table 2. Comparison of analytical methods used in detecting TTX levels in Asian patients, 1989–2008. 
Incident 
Time 
Location 
Patients 
Involved 
Detection 
Method 
LOD (ng/mL) 
TTX Conc. in 
Urine (ng/mL) 
TTX Conc. in 
Plasma/Serum (ng/mL) 
Reference 
2008  Bangladesh  141  ELISA  Not mentioned  0.4 to 75.4  <1.6 to 13.7  [13] 
2007  Hong Kong  1  LC-MS/MS  0.13  88.2  N/A  [38] 
2006  Hong Kong  4  LC-MS/MS  0.13  30.7 to 460.5  <0.13  [38] 
2006  Taiwan  3  LC-MS/MS  0.1  N/A  3.3  [39] 
2005  Hong Kong  3  LC-MS/MS  0.13  59.3 to 109.6  < 0.13  [38] 
2005  Taiwan  6  LC-MS  1.0  169 to 325  <1 to 8  [12] 
2004  Japan  7  LC-MS/MS  0.1  15 to 150  0.9 to 1.8  [40] 
2001  Taiwan  6  LC-MS  4.9  15 to 109.7  <4.9 to 13  [11] 
1989–1996  Japan  6  HPLC-FLD  2.0  6 to 102  N/A  [33] 
Not mentioned  Japan  11  GC-MS  0.5  15 to 650  2.5 to 320  [41] 
N/A: not available. 
Table 3. Summary of different analytical techniques for TTX determination in human urine and/or blood. 
Analytical 
Method 
Analytical 
Column 
LC Mobile Phase  Sample Preparation  LOD (ng/mL)  Reference 
  Urine  Plasma/Serum   
ELISA  -  - 
Ultrafiltered through an  
Ultracel YM-50 membrane  
(50000 Da cut-off) 
Same as urine  Not mentioned  [13] 
LC-UV 
Allsphere ODS-2, 
5 μm,  
250 × 4.6 mm 
1-heptanesulfonic acid sodium salt 
monohydrate, sodium dihydrogen 
phosphate anhydrous, methanol 
SPE: C18 Sep-Pak and HiTrap 
(weak cation exchange) columns 
Same as urine  10  [34] 
LC-FLD 
Nova-Pak C18, 
4 μm, 100 × 8 mm 
Heptanesulfonic acid, acetonitrile 
SPE: C18 Sep-Pak and Strata  
X-C cation Mixed-mode  
polymer cartridge 
Oasis MCX  s: 5; u: 20  [29] Mar. Drugs 2011, 9                                             
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Table 3. Cont. 
LC-FLD 
Inertsil ODS-2, 
250 × 4.6 mm 
Sodium potassium phosphate with 
sodium dodecyl sulfate 
SPE: Bond Elut SCX  
cartridge 
N/A  Not mentioned  [42] 
GC-MS 
DB-5 fused silica 
capillary column, 
30 m × 0.25 mm 
i.d. film thickness 
5 μm 
-  Sep-Pak C18 columns  Similar to urine  s: 0.5; u: 1  [42] 
LC-MS/MS 
Atlantics dC18, 
5 μm, 
150 × 2.1 mm 
Heptafluorobutyric acid, ammonium 
formate with formic acid, 
acetonitrile 
SPE: Sep-Pak C18 and  
HILIC columns 
Same as urine  0.13  [38] 
LC-MS 
Zorax 300SB-C3, 
150 × 4.6 mm 
Trimethylamine, ammonium 
formate, acetonitrile 
SPE: Sep-Pak C18 and 
ultrafiltration 
Same as urine  4.97  [11] 
LC-MS/MS 
Cosmosil Hilic 
150 × 4.6 mm 
Formic acid, methanol  N/A 
SPE: Oasis 
MCX and 
ultrafiltration 
0.1  [39] 
LC-MS/MS 
GC Science 
ODS-3 
3 μm, 50 × 2.1 mm 
ion pair reagent and methanol 
Methacrylate-
styrenedivinylbenzene  
cartridge 
Same as urine  0.1  [40] 
LC-MS/MS 
Zorbax 300SB-C3, 
150 × 4.6 mm 
Trimethylamine, ammonium 
formate, acetonitrile 
Sep-Pak C18 and ultrafiltration  Same as urine  1  [12] 
LC-MS/MS  TSK-gel amide-80 
Ammonium formate, methanol, 
acetonitrile 
Protein precipitation  Same as urine  s: 0.3; u: 1  [43] 
LOD: limit of detection; SPE: solid phase extraction; N/A: not applicable; s: serum; u: urine. 
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2.2. Determination of TTX in Human Urine and Blood by ELISA 
Islam et al. [13] measured the TTX concentrations in urine and blood from 38 patients from the 
large outbreaks of TTX poisoning in Bangladesh using the ELISA method according to the method of 
Ngy et al. [36] using a monoclonal anti-TTX antibody developed by Kawatsu et al. [37]. Samples were 
centrifuged  at 16,100 g for 10 min, and then ultrafiltrated through an Ultracel YM-50 membrane 
(50,000 Da cut-off; Millpore, Bangalore, India). The filtrates were then analyzed by ELISA for   
TTX determination.  
2.3. Determination of TTX in Human Urine and Blood by LC-UV 
Yu et al. [34] developed a method of HPLC coupled with UV detection for the analysis of TTX in 
human urine and plasma. Samples are treated by Sep-Pak C18 cartridge (Sep-Pak cartridge Vac, Waters, 
Australia) followed by a weak cation exchange column. An Allsphere ODS-2, 5 μm, 250 × 4.6 mm 
analytical column was employed. The detection limit of their method was 10 ng/mL. Although the 
instrument  set  up  is  simple,  the  assay  sensitivity  may  not  be  appropriate  for  patients  with  late 
admission to hospital after puffer fish ingestion.  
2.4. Determination of TTX in Human Urine and Plasma by LC-FLD 
Yasumoto and Mitishita [44] developed a method to determine TTX by HPLC with post-column 
derivatization and fluorescence detection in 1985. O’Leary et al. [29] refined their method in 2004 and 
used  it  to  determine  TTX  in  human  urine  and  serum.  Samples  were  cleaned  up  by  solid  phase 
extraction, and then analyzed by HPLC with post-column derivatization and fluorescence detection. 
However, post-column derivatization involves the use of hot and concentrated NaOH to convert TTX 
into 2-amino-6-hydroxymethyl-8-hydroxyquinazoline (so-called “C9 base”) to produce the fluorescent 
signal; this limits the recovery of TTX. The minimum quantifiable concentrations of TTX reported 
were 5 and 20 ng/mL for serum and urine, respectively. Due to the relatively poor assay sensitivity, 
this method is mainly used for urine specimen as urine typically contains a higher concentration of 
TTX than blood. 
2.5. Determination of TTX in Human Urine and Plasma by GC-MS 
TTX is soluble only in acidic alcohols and cannot be analyzed by GC/MS in its original form. TTX 
should be treated with alkali to form 2-amino-6-hydroxymethyl-8-hydroxyquinazoline (“C9 base”), 
which can then be trimethylsilylated for GC/MS analysis. For body fluid and blood plasma, additional 
extraction steps are required which include passing through Sep-Pak C18 cartridge twice [42]. The first 
Sep-Pak C18 cartridge is used only for removal of hydrophobic impurities. The second Sep-Pak C18 
cartridge is used for extraction of the C9 base produced by the alkali treatment. The detection limit of 
this method for body fluid is 1 ng/mL and for blood plasma is 0.5 ng/mL. The lengthiness of sample 
preparation of this process compels researchers to look for an alternative method.  Mar. Drugs 2011, 9                                             
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2.6. Determination of TTX in Human Urine and Plasma by LC-MS (MS) 
This is the most popular method for determination of TTX in human urine and plasma/serum due to 
its superiority in assay sensitivity and ease of sample clean up. The major challenge lies in solving 
problems of ion suppression when analyzing TTX in urine samples by LC-MS methods. Endogenous 
metabolites in urine are very polar compounds, just like TTX, which may pose the problem of ion 
suppression  in  LC-MS  analysis.  From  reports  in  the  literature  one  may  conclude  that  combined 
methods  for  sample  clean  up  are  required,  either  solid  phase  extraction  (SPE)  followed  by 
ultrafiltration [11,12,39], or double SPE [38]. For the one using simple sample clean up method [43], a 
HILIC column was employed as analytical column for TTX separation. 
Various LC-MS methods have been reported in recent years. Tsai et al. [11] used a Sep-Pak C18 
cartridge  and  filtered  through  a  3000  MW  cut-off  Ultrafree  microcentrifuge  filter  (Micron  YM-3, 
Millipore, Waters) as sample preparation, and the detection of TTX was accomplished using positive 
ion electrospray ionization (ESI)-LC-MS. The analytical column was Zorax 300SB-C3, and the mobile 
phase was composed of 1% acetonitrile, 10 mM trimethylamine, 10 mM ammonium formate at pH 4.0. 
Jen et al. [39] used an Oasis MCX cartridge (Millipore, Waters, USA) followed by filtration through a 
3000 MW cut-off ultrafree microcentrifuge filter for sample clean-up, and detection by LC-MS/MS. 
The study used a Waters Cosmosil Hilic column with gradient elution with 0.1% formic acid and 
methanol as mobile phases. The total run time was 15 min included the time for re-equilibration. The 
detection limit was 1 ng/mL in blood serum. Table 3 summarizes other LC-MS/MS methods. 
Despite  the  fact  that  reversed  phase  liquid  chromatography  (RPLC)  is  overall  the  most  used 
separation technique, certain solutes, especially polar and hydrophilic compounds like TTX, are not 
retainable in a simple fashion. Over a long period normal phase liquid chromatography (NPLC) has 
been  the  technique  of  choice  for  this  purpose.  The  introduction  of  hydrophilic  interaction  liquid 
chromatography (HILIC) makes the analysis of polar compound easier. The HILIC technique bears 
similar  features  with  traditional  NPLC,  but  with  the  important  difference  that  HILIC  employs  
semi-aqueous mobile phases. Consequently, with respect to analyte solubility in the eluent and matrix 
compatibility, HILIC is superior, as the mobile phase compositions used are comparable to RPLC 
separations and thus a very MS-friendly technique. HILIC columns contain a stationary phase that is 
hydrophilic and often charged, at least in some region of the pH-scale. Compounds on the column 
interact with the stationary phase, and is generally more strongly retained than the more hydrophilic 
the  compound.  Our  previous  publication  [38]  used  Superclean  LC18  (Supelco,  USA)  and  HILIC 
cartridges  (SeQuant  ZIC-HILIC  SPE  cartridge,  Sweden)  as  sample  clean-up  procedure  for  the 
determination of TTX in human urine and plasma before detection by LC-MS/MS. We found that both 
Superclean LC18 and Sep-Pak cartridges could retain hydrophobic substances in the sample but could 
not retain TTX. The eluates from Superclean LC18 or Sep-Pak cartridges are further cleaned by the 
HILIC cartridge to remove interferences that eluted close to TTX peak and therefore fixed the problem 
of ion suppression.  
Since TTX is a very polar compound, there will be lack of retention on conventional reverse-phase 
columns.  To  solve  this  problem,  one  may  use  an  HILIC  column  as  the  analytical  column  as 
documented by Zhang and Cai; and Nakagawa et al. [43,45]. Our previous study [38] used an ion pair 
reagent, heptafluorobutyric acid, to solve the problem of analyzing a very polar compound in RPLC. Mar. Drugs 2011, 9                                             
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An  Atlantics  dC18  column  was  used,  with  isocratic  elution  of  a  single  mobile  phase  containing  
10 mmol/L ammonium formate with formic acid (95:5, v/v), with 5 mM heptafluorobutyric acid and 
2% acetonitrile, total run time is 5.5 min. 
3. Correlation between Blood and Urine TTX Concentrations and Poisoning Symptoms 
3.1. Blood TTX Concentrations and Intoxication Symptoms 
Although a number of TTX intoxication case reports have been published [10,26,46,47] most do not 
report the urine and/or blood TTX concentrations in patients. Zimmer has tried to find correlation 
between  blood  TTX  concentrations  and  the  poisoning  symptoms  [48].  All  available  blood  TTX 
concentrations were plotted against the intoxication grade of the corresponding patients. For those 
classified as first and second degree in the four-degree classification, blood levels were similar to or 
lower than the IC50 (half maximal inhibitory concentration) of TTX sodium channels. In severe cases, 
i.e.,  fourth  degree,  TTX  concentrations  of  12.8–52.7 ng/mL were  reported.  In the recent large 
outbreaks of TTX poisoning in Bangladesh in 2008, 141 patients involved. Islam et al. [13] reported 
that symptoms developed after the consumption of less than approximately 50 g of puffer fish. Seven 
patients died after eating more than 100 g of puffer fish. They also found there appeared to be a strong 
correlation between blood TTX levels and the development of paralysis and respiratory arrest. Five 
patients who died within 15–30 minutes and 2 who died about 4 h after admission exhibited blood 
TTX concentrations > 9 ng/mL. Only 3 patients with TTX concentrations of 9.3–10.0 ng/mL survived. 
They  suggested that TTX  concentrations greater than 9 ng/mL are potentially lethal, leading to 
respiratory arrest. 
3.2. Urine TTX Concentrations and Intoxication Symptoms 
Our group previously reported a case series of 8 patients with TTX intoxication and TTX was 
detected in all the urine samples but not in any blood plasma [38]. This demonstrated that TTX only 
remains  in  the  blood  for  a  short  time,  and  results  agree  with  observations  described  in  previous  
works [11,29,34]. In order to eliminate the effect of dehydration and variations in urinary output, 
creatinine adjustment was made for all urine samples. It was found that the creatinine-adjusted TTX 
concentrations  (UC-TTX)  in  urine  correlate  well  with  the  degree  of  poisoning.  For  patients  with  
UC-TTX greater than 20 ng/μmol creatinine were found to have liver derangement as evidenced by 
increases  in  liver  enzymes.  A case with very high  urine  TTX  levels  (41.1  ng/μmol  creatinine;  
460.5 ng/mL) showed sinus rhythm with ST 1 mm elevation over V2-V4 in the electrocardiogram, 
suggested myocardial infarction of the anterior wall of the heart.  
Although Islam’s group [13]  found a strong correlation between blood TTX levels and the 
developed symptoms, urine TTX levels were not correlated to either blood TTX levels or intoxication 
symptoms. However, there was no creatinine adjustment being made for urine TTX levels, and the 
difference of hydration state of patients would significantly alter the excretion of TTX. The expression 
of absolute amount of TTX in urine alone was difficult to interpret. The findings could also be due to 
time differences in blood and urine sampling. Mar. Drugs 2011, 9                                             
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Apart from the above findings, one should bear in mind that the severity of symptoms and prognosis 
generally  depends  on  the  amount  of  toxin  ingested,  and  the  patient’s  overall  health  and/or  other 
medical conditions, such as diabetic neuropathy, neural myoinositol and Na-K-adenosine-triphosphatase 
deficiency [49,50] as well as natural variation in individual sensitivity to the toxin. 
4. Conclusions  
The application of LC-MS/MS to clinical analysis has evolved considerably since it was first used, 
both  in  research  facilities  and  for  routine  analysis  in  clinical  biochemistry  laboratories.  Initially  
GC-MS was used for biological analysis, but the requirement that GC needs a volatile analyte meant 
that elaborate extraction and derivatization protocols were needed for analysis of the typically polar, 
involatile biomolecules found in clinical samples. LC is a much more appropriate separation technique 
for these polar molecules found in biological samples. It also reduces the need for derivatization to 
volatile molecules. It is the coupling of LC to MS that led to the adoption of clinical MS. However, the 
determination of small polar molecules in biological samples is often challenging due to the lack of 
retention on conventional reverse-phase columns and significant ion suppression due to endogenous 
substances  in  human  urine  and  plasma.  The  development  of  the  HILIC  stationary  phase,  as  an 
analytical column or in sample preparation cartridge, partly helps solve this problem. With continuous 
improvement and advancement in LC and MS technology, it is expected that determination of other 
toxins in human urine and blood plasma will soon be published.  
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